Elsevier Inc.

SHERPA: Unknown

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Jakubowski
    Jakubowski
  4. O'Reilly
    O'Reilly
  5. Papadopoulos
    Papadopoulos
  6. Castro-Malaspina
    Castro-Malaspina
  7. Van Den Brink
    Van Den Brink
  8. Young
    Young
  9. Devlin
    Devlin
  10. Maloy
    Maloy

Groups

  1. Bone Marrow Transplant (58)
  2. Center for Hematologic Malignancies (58)
  3. Department of Medicine (58)
  4. GSK Faculty (58)
  5. Hematologic Malignancies, Division of (58)
  6. Immunology Program Faculty (58)
  7. Sloan Kettering Institute Faculty (58)
  8. Survivorship Research (58)
  9. Pediatrics, Department of (43)
  10. Stem Cell Transplantation and Cellular Therapy Service (42)
Search Within
  1. "Bone Marrow Transplant"
  2. "Survivorship Research"
  3. "Meeting abstract"
  4. "Immunology Program Faculty"
Formats
  1. Meeting Abstract (58)
Groups
  1. Bone Marrow Transplant (58)
  2. Center for Hematologic Malignancies (58)
  3. Department of Medicine (58)
  4. GSK Faculty (58)
  5. Hematologic Malignancies, Division of (58)
  6. Immunology Program Faculty (58)

More Groups

People
  1. Miguel-Angel Perales (47)
  2. Sergio Giralt (46)
  3. Ann Jakubowski (41)
  4. Richard O'Reilly (41)
  5. Esperanza Papadopoulos (40)
  6. Hugo Castro-Malaspina (39)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (6)
  5. 2019 (5)
  6. 2018 (10)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (54)
  2. Clinical Lymphoma, Myeloma and Leukemia (4)

Results (58)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Providing nutritional guidance for patients with plasma cell disorders - A missed opportunity for hematologists and oncologists?
    Meeting Abstract

    Sweeney, N.; Malik, M.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P.; Mailankody, S.; Korde, N.; Tan, C.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets
    Meeting Abstract

    Shah, U.; Derkach, A.; Adintori, P.; Cross, J.; Maclachlan, K.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Population pharmacokinetic model demonstrates poor outcomes with ATG overexposure in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell
    Meeting Abstract

    Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; Shah, G. L.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save